TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Unimedic Pharma Holding AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 2,668 | 2,705 | 2,099 |
Financial expenses | 1,135 | 971 | 1,051 |
Earnings before taxes | -2,094 | -1,327 | -1,150 |
EBITDA | -1,038 | -381 | -119 |
Total assets | 54,289 | 55,391 | 56,019 |
Current assets | 2,088 | 846 | 837 |
Current liabilities | 5,073 | 9,062 | 4,799 |
Equity capital | 212 | 363 | 639 |
- share capital | 200 | 218 | 222 |
Employees (average) | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 0.4% | 0.7% | 1.1% |
Turnover per employee | 700 | ||
Profit as a percentage of turnover | -78.5% | -49.1% | -54.8% |
Return on assets (ROA) | -1.8% | -0.6% | -0.2% |
Current ratio | 41.2% | 9.3% | 17.4% |
Return on equity (ROE) | -987.7% | -365.6% | -180.0% |
Change turnover | 182 | 646 | 1,728 |
Change turnover % | 7% | 31% | 466% |
Chg. No. of employees | 0 | -3 | 3 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.